Mark S. Blumenkranz insider trades: Avalanche Biotechnologies stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
and 1 more company
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 11, 2015 | [AAVL] | ↓ Sell | 1,900 | $39.97 | $76K | Direct | Jun 15, 2015 (4d) |
| Jun 10, 2015 | [AAVL] | ↓ Sell | 23,100 | $35.86 | $828K | Direct | Jun 11, 2015 (1d) |
| Jun 5, 2015 | [AAVL] | ↓ Sell | 5,000 | $40.08 | $200K | Direct | Jun 8, 2015 (3d) |
| May 19, 2015 | AAVL | ↓ Sell | 1,000 | $36.91 | $37K | Indirect | May 21, 2015 (2d) |
| May 15, 2015 | [AAVL] | ↓ Sell | 22,500 | $35.49 | $799K | Direct | May 18, 2015 (3d) |
| May 13, 2015 | [AAVL] | ↓ Sell | 715 | $34.94 | $25K | Direct | May 13, 2015 (0d) |
| May 11, 2015 | [AAVL] | ↓ Sell | 1,785 | $34.91 | $62K | Direct | May 12, 2015 (1d) |
| May 1, 2015 | AAVL | ↓ Sell | 20,000 | $32.37 | $647K | Direct | May 5, 2015 (4d) |
| Apr 16, 2015 | AAVL | ↓ Sell | 25,000 | $41.59 | $1.0M | Direct | Apr 20, 2015 (4d) |
| Apr 8, 2015 | AAVL | ↓ Sell | 25,000 | $38.74 | $968K | Direct | Apr 8, 2015 (0d) |
| Apr 7, 2015 | AAVL | ↓ Sell | 1,000 | $38.60 | $39K | Indirect | Apr 8, 2015 (1d) |
| Jan 13, 2015 | AAVL | ↓ Sell | 100,000 | $55.46 | $5.5M | Direct | Jan 15, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark S. Blumenkranz's insider trades
Mark S. Blumenkranz is a director at Avalanche Biotechnologies. Since Jan 13, 2015, Mark has reported no open-market purchases and 12 sales worth $10.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (6 filings), shares returned to the company (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.